Atomoxetine and DAW2022 on OSA Severity (NCT05350215)
Effect of Atomoxetine and DAW2022 on OSA Severity
🩺 Plain-English Summary (8th-Grade Level)
Obstructive sleep apnea (OSA) is common and has major health implications but treatment options are limited. In previous research atomoxetine and oxybutynin showed promising effect at reducing OSA severity, however they reduced arousal threshold, one of the key traits responsible for OSA. Since oxybutynin was used mainly as a hypnotic, but it is burdened by several anti-cholinergic side effects, DAW2020, a hypnotic which prolonged the total sleep time in a previous trial in OSA patients, could be a better candidate to associate with atomoxetine.
Who can join: Review the eligibility criteria below.
Location: Brigham and Women's Hospital — Boston, Massachusetts
Age range: 21 Years to 70 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Brigham and Women's Hospital — Boston, Massachusetts
📞 Contact the Study Coordinator
Phone: (857) 272-6188
Email: lmessineo@bwh.harvard.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Obstructive Sleep Apnea
- RPMO2 Oximeter Accuracy During Sleep 1 Trial — Dallas, Texas
- Validation of Sleep Questionnaires in the Down Syndrome Population — Portland, Oregon
- 3D Printer Modified CPAP Mask for Obstructive Sleep Apnea — Boston, Massachusetts
- Breathing Training for Improving Cardiovascular Health in Older Adults With Sleep Apnea — Tucson, Arizona
- Obstructive Sleep Apnea in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation — Memphis, Tennessee
- Obstructive Sleep Apnea (OSA) and Sex-Specific Responses to N-acetylcysteine (NAC) — New York, New York
Explore by condition: All Obstructive Sleep Apnea clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.